Seres Therapeutics, Inc. (MCRB) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

bluebird bio, Inc.

MaxCyte, Inc.

Nuvation Bio, Inc.

Humacyte, Inc.

uniQure NV

23andMe Holding Co.

MeiraGTx Holdings Plc

Terns Pharmaceuticals, Inc.

Zura Bio Ltd.

Seres Therapeutics, Inc.

Renovaro, Inc.

Why is Seres Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Seres Therapeutics, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Seres Therapeutics, Inc.

-35.91%

0.49

2088.49%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-56.80%

EBIT Growth (5y)

-3.35%

EBIT to Interest (avg)

-23.74

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.99

Sales to Capital Employed (avg)

0.98

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

34.82%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.90

EV to EBIT

-0.44

EV to EBITDA

-0.47

EV to Capital Employed

7.58

EV to Sales

45.30

PEG Ratio

0.10

Dividend Yield

ROCE (Latest)

-1729.87%

ROE (Latest)

12.34%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company

NET SALES(9M)

At USD 0.35 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Highest at USD -23.05 MM

ROCE(HY)

Highest at 15.95%

PRE-TAX PROFIT(Q)

At USD 8.2 MM has Grown at 116.08%

NET PROFIT(Q)

At USD 8.2 MM has Grown at 116.08%

OPERATING PROFIT(Q)

Highest at USD -21.43 MM

-3What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 19,744% (YoY

CASH AND EQV(HY)

Lowest at USD 93.02 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

Here's what is working for Seres Therapeutics, Inc.

Net Sales

At USD 0.35 MM has Grown at inf%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (USD MM)

Pre-Tax Profit

At USD 8.2 MM has Grown at 116.08%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit

At USD 8.2 MM has Grown at 116.08%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Operating Cash Flow

Highest at USD -23.05 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit

Highest at USD -21.43 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Here's what is not working for Seres Therapeutics, Inc.

Cash and Eqv

Lowest at USD 93.02 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 19,744% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales